Protection against influenza virus encephalitis by adoptive lymphocyte transfer

Virology

Volumn 232, Issue 1, 1997, Pages 158-166

  Stevenson, P G ^b   Hawke, S ^a   Bangham, C R M ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE ACTIVATION; CYTOTOXIC T LYMPHOCYTE; FEMALE; IMMUNOSTIMULATION; INFECTION PREVENTION; INFLUENZA VIRUS; MALE; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRUS ENCEPHALITIS;

EID: 0031007317     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8535     Document Type: Article

References (45)

1. Ahmed R., Jamieson B. D., Porter D. D. Immune therapy of a persistent and disseminated viral infection. J. Virol. 61:1987;3920-3929.
2. Baezinger J., Hengartner H., Zinkernagel R. M., Cole G. A. Induction or prevention of immunopathological disease by cloned cytotoxic T cell lines specific for lymphocytic choriomeningitis virus. Eur. J. Immunol. 16:1986;387-393.
3. Barrett T., Inglis S. C. Growth and purification of influenza virus. Virology - A Practical Approach. 1985;IRL press, Oxford. p. 119-150.
4. Berke G. The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects. Annu. Rev. Immunol. 12:1994;735-773.
5. Bonin J., Scholtissek C. Mouse neurotropic recombinants of influenza A viruses. Arch. Virol. 75:1983;255-268.
6. Dailey M. O., Fathman C. G., Butcher E. C., Pillemer E., Weissman I. Abnormal migration of T lymphocyte clones. J. Immunol. 128:1982;2134-2136.
7. Doherty P. C., Gerhard W. Breakdown of the blood-cerebrospinal fluid barrier to immunoglobulin in mice injected intracerebrally with a neurotropic influenza A virus. J. Neuroimmunol. 1:1981;227-237.
8. Doherty P. C., Allan W., Eichelberger M. Roles of αβ and γδ T cell subsets in viral immunity. Annu. Rev. Immunol. 10:1992;123-151.
9. Effros R. B., Doherty P. C., Gerhard W., Bennink J. Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses. J. Exp. Med. 145:1977;557-568.
10. Finke D., Brinckmann U. G., ter Meulen V., Liebert U. G. Gamma interferon is a major mediator of antiviral defense in experimental measles virus-induced encephalitis. J. Virol. 69:1995;5469-5474.
11. Ford W. L. Lymphocyte migration and immune responses. Prog. Allergy. 19:1975;1-59.
12. Griffin D. E., Levine B., Ubol S., Hardwick J. M. The effects of alphavirus infection on neurons. Ann. Neurol. 35:1994;S23-S27.
13. Johnson R. T. Viral Infections of the Nervous System. 1982;Raven Press, NY. p. 443-.
14. Joly E., Mucke L., Oldstone M. B. A. Viral persistence in neurons explained by lack of major histocompatibility class I expression. Science. 253:1991;1283-1285.
15. Kawaoka Y. Equine H7N7 influenza A viruses are highly pathogenic in mice without adaptation: Potential use as an animal model. J. Virol. 65:1991;3891-3894.
16. Kos F. J., Mullbacher A. Specific epitope-induced conversion of CD8+ memory cells into effector cytotoxic T lymphocytes in vitro: Presentation of peptide antigen by CD8+ T cells. Eur. J. Immunol. 22:1992;1595-1601.
17. Kundig T. M., Hengartner H., Zinkernagel R. M. T cell-dependent IFN-γ exerts an antiviral effect in the central nervous system but not in peripheral solid organs. J. Immunol. 150:1993;2316-2321.
18. Liang S., Mozdzanowska K., Palladino G., Gerhard W. Heterosubtypic immunity to influenza type A virus in mice. J. Immunol. 152:1994;1653-1661.
19. Mims C. A. Intracerebral injections and the growth of viruses in the mouse brain. Brit. J. Exp. Pathol. 41:1959;52-59.
20. Mims C. A. An analysis of the toxicity for mice of influenza virus - I. Intracerebral toxicity. Brit. J. Exp. Pathol. 41:1960;586-595.
21. Nonacs R., Humborg C., Tam J. P., Steinman R. M. Mechanisms of mouse spleen dendritic cell function in the generation of influenza-specific, cytolytic T lymphocytes. J. Exp. Med. 176:1992;519-529.
22. Oldstone M. B. A., Blount P., Southern P. J., Lampert P. W. Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system. Nature. 321:1986;239-243.
23. Palladino G., Mozdzanowska K., Washko G., Gerhard W. Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice. J. Virol. 69:1995;2075-2081.
24. Planz O., Bilzer T., Sobbe M., Stitz L. Lysis of major histocompatibility class I bearing cells in Borna disease virus induced encephalopathy. J. Exp. Med. 178:1993;163-174.
25. Ravenholt R. T., Foege W. H. 1918 influenza, encephalitis lethargica, parkinsonism. Lancet. 2:1982;860-864.
26. Rooney C. M., Smith C. A., Ng C. Y., Loftin S., Li C., Krance R. A., Brenner M. K., Heslop H. E. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet. 345:1995;9-13.
27. Schiltknecht E., Ada G. L. In vivo effects of cyclosporine on influenza A virus infected mice. Cell. Immunol. 91:1985;227-239.
28. Simmons A., Tscharke D. C. Anti-CD8 impairs clearance of Herpes simplex virus from the nervous system: implications for the fate of virally infected neurons. J. Exp. Med. 175:1992;1337-1344.
29. Sprent J. Fate of H2-activated T lymphocytes in syngeneic hosts. Cell. Immunol. 21:1976;278-302.
30. Stevenson P. G., Hawke S., Bangham C. R. M. Protection against lethal influenza virus encephalitis by intranasally primed CD8+ memory T cells. J. Immunol. 157:1996;3065-3073.
31. Stohlman S. A., Bergmann C. C., van der Veen C. R., Hinton D. R. Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system. J. Virol. 69:1995;684-694.
32. Stuart-Harris C. H. A neurotropic strain of human influenza virus. Lancet. 1:1939;497-499.
33. Sussman M. A., Shubin R. A., Kyuwa S., Stohlman S. A. T-cell-mediated clearance of mouse hepatitis virus strain JHM from the central nervous system. J. Virol. 63:1989;3051-3056.
34. Takahashi M., Yamada T., Nakajima S., Nakajima K., Yamamoto T., Okada H. The substantia nigra is a major target for neurovirulent influenza A virus. J. Exp. Med. 181:1995;2161-2169.
35. Taylor P. M., Askonas B. A. Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in vivo. Immunology. 58:1986;417-420.
36. Townsend A. R. M., McMichael A. J., Carter N. P., Huddleston J. A., Brownlee G. G. Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells. Cell. 39:1984;13-25.
37. Tyor W. R., Griffin D. E. Virus specificity and isotype expression of intraparenchymal antibody-secreting cells during Sindbis virus encephalitis in mice. J. Neuroimmunol. 48:1993;37-44.
38. Virelizier J-L. Host defenses against influenza virus: the role of anti-hemagglutinin antibody. J. Immunol. 115:1975;434-439.
39. Walter E. A., Greenberg P. D., Gilbert M. J., Finch R. J., Watanabe K. S., Thomas E. D., Riddell S. R. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333:1995;1038-1044.
40. Webster R. G., Askonas B. A. Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice. Eur. J. Immunol. 10:1980;396-401.
41. Webster R. G., Laver W. G., Air G. M., Schild G. C. Molecular mechanisms of variation in influenza viruses. Nature. 296:1982;115-121.
42. Yamaguchi K., Goto N., Kyuwa S., Hayami M., Toyoda Y. Protection of mice from a lethal coronavirus infection in the central nervous system by adoptive transfer of virus-specific T cell clones. J. Neuroimmunol. 32:1991;1-9.
43. Yap K. L., Ada G. L., McKenzie I. F. C. Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature. 273:1978;238-239.
44. Yolken R. H., Torrey E. F. Viruses, schizophrenia and bipolar disorder. Clin. Micro. Rev. 8:1995;131-145.
45. Zweerink H. J., Courtneige S. A., Skehel J. J., Crumpton M. J., Askonas B. A. Cytotoxic T cells kill influenza infected cells but do not distinguish between serologically distinct type A viruses. Nature. 267:1977;354-356.